Anti-HIV agents. Effectiveness of etravirine in treatment-experienced PHAs.
D018791:CD4 Lymphocyte Count; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006297:Health Services Accessibility; D006801:Humans; D008297:Male; D009570:Nitriles; D011724:Pyridazines / Q000009:adverse effects / Q000600:supply & distribution / Q000627:therapeutic use*; D011743:Pyrimidines; D016032:Randomized Controlled Trials as Topic; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects / Q000600:supply & distribution / Q000627:therapeutic use*; D016896:Treatment Outcome; D019562:Viral Load
D009570:Nitriles; D011724:Pyridazines; D011743:Pyrimidines; D018894:Reverse Transcriptase Inhibitors; C451734:etravirine